Phar­ma mar­ket­ing 2022: More dig­i­tal shifts for reps, ads and drug launch­es, plus rep­u­ta­tion and the meta­verse

Whether you call it the new nor­mal, the next nor­mal or just a ma­jor shift, phar­ma mar­ket­ing will nev­er be the same thanks to the Covid-19 pan­dem­ic.

From the ac­cel­er­a­tion of dig­i­tal strate­gies and com­mu­ni­ca­tion to rep­u­ta­tion boosts be­yond what any­one could have imag­ined, phar­ma and biotech mar­ket­ing is on a per­ma­nent new path. And while some of that path is still un­der con­struc­tion and will con­tin­ue for the next sev­er­al years, ex­perts pre­dict some de­fined trends for 2022.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.